This funding opportunity encourages research to deepen understanding of the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias. It supports studies exploring biobehavioral and neurobiological pathways and aims to identify novel therapeutic targets that could lead to interventions to treat or prevent these symptoms. Clinical trials are optional within this research scope.
Eligible applicants include a wide range of organizations such as nonprofits, for-profits, small businesses, tribal governments, educational institutions, government entities, and foreign organizations. Specific eligibility details are provided in the announcement.
